Labiotech.eu

News and Trends 20 Jul 2018

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

Belgian biotech ThromboGenics has conducted the first clinical trial of an antibody to treat one of the world’s leading causes of vision loss. Results from the Phase I/II trial demonstrate the safety and tolerability of a new kind of antibody treatment for diabetic macular edema. The trial focused on injecting the THR-317 antibody, which is directed against […]

July 20, 2018 - 2 minutesmins - By External Contributor

News and Trends 20 Jul 2018

German Private Equity Firm Raises €90M for Life Sciences and Medtech

SHS has raised €90M in the first closing of its fifth fund dedicated to companies in life sciences and medtech. SHS, based in Tübingen, is aiming to raise a total of €150M for its fifth fund. In this first closing, around half of the €90M raised came from existing investors including professional pension insurers and family […]

July 20, 2018 - 1 minutemin - By Alexander Burik

News and Trends 19 Jul 2018

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. The developer of one of only two CAR-T therapies currently in the market, Kite, has […]

July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 18 Jul 2018

Lab-Grown Meat Will Be on the Market in 2021

Dutch startup Mosa Meat has raised €7.5M in a Series A round, which will support the development of a first lab-grown meat product that is expected to make it to market by 2021. Mosa Meat is a Dutch startup co-founded by Mark Post, the scientist behind the world’s first lab-grown burger. After an early investment […]

July 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the womb. A research team from the UK and Singapore showed that a neurodegenerative condition called Gaucher disease, which can be fatal, can be prevented in […]

July 17, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 16 Jul 2018

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Researchers at the Wellcome Trust Sanger Institute in the UK have found that gene editing with CRISPR-Cas9 can cause significantly more off-target damage to the DNA than previously thought. Published today in Nature Biotechnology, the study is the first to look at unexpected DNA changes caused by CRISPR across large regions of the genome. […]

July 16, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Sickle Cell Disease Modus Therapeutics Cover

News and Trends 16 Jul 2018

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

Modus Therapeutics closed SEK 140M (€13.5M) in Series A financing to complete a Phase II study testing its sickle cell disease drug and to prepare for further clinical trials. The financing round was led by HealthCap, a European venture capital firm focused on life science investments, which will contribute SEK 60M (€5.8M). The remaining funds […]

July 16, 2018 - 3 minutesmins - By Alexander Burik

Flow State Francis Crick Institute Alex May

More News! 14 Jul 2018

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

A new interactive art installation at the Francis Crick Institute in London lets visitors peek into what life at the famous research institute is like. “The Francis Crick Institute is this incredible, huge, imposing building of which the public can see very little inside,” Alex May, a British digital artist, told me during an interview. His […]

July 14, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Jul 2018

French Biotech Raises €12.5M for Antibiotic Booster Drugs

French-biotech Antabio closed €12.5M at series A to fund its pipeline of antibiotic booster drugs that should help in the global fight against antimicrobial resistance. After raising €7.3M last year, Antabio extended its Series A financing round with €5.2M of additional funding raised from private investors. The French biotech will use the funding to continue […]

July 13, 2018 - 2 minutesmins - By Alexander Burik

In Depth 12 Jul 2018

How Plant Biotechnology Can Give Us Better Food and Medicines

From super crops to better medicines, biotechnology from plants could make a big difference in our lives. Here’s how. What have plants ever done for us? Well, a colossal amount of things. Throughout human history, they have fed us, made medicinal compounds, given us clothes, produced oxygen and much more. However, what if there were […]

July 12, 2018 - 4 minutesmins - By Jonathan Smith

News and Trends 12 Jul 2018

Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies

Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer targets. Genmab has offered Immatics, based in Tuebingen, Germany, an upfront payment of $54M (€46M) in addition to milestone payments worth up to $550M (€470M) for each product. Genmab has a market cap of €60Bn ($70Bn). The funding will be […]

July 12, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 11 Jul 2018

Radioactive Nanoparticle Could Improve Cancer Diagnoses

Isotopia Molecular Imaging, an Israeli company, is developing a radioactive marker made of gold nanoparticles to detect cancer more accurately than with current diagnostic tools. PET and CT scans are two types of X-ray tests that use small quantities of radioactive materials, called contrast agents, to help visualize and assess organ and tissue function. These […]

July 11, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

German Private Equity Firm Raises €90M for Life Sciences and Medtech

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Lab-Grown Meat Will Be on the Market in 2021

Gene Therapy Could Prevent Deadly Brain Disease

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

An Artist’s Insight into the Day-to-Day Life at the Francis Crick Institute

French Biotech Raises €12.5M for Antibiotic Booster Drugs

How Plant Biotechnology Can Give Us Better Food and Medicines

Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies

Radioactive Nanoparticle Could Improve Cancer Diagnoses

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!